Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease

BACKGROUND: Outcomes are unpredictable for neurological presentations of Wilson's disease (WD). Dosing regimens for chelation therapy vary and monitoring depends on copper indices, which do not reflect end‐organ damage. OBJECTIVE: To identify a biomarker for neurological involvement in WD. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Shribman, Samuel, Heller, Carolin, Burrows, Maggie, Heslegrave, Amanda, Swift, Imogen, Foiani, Martha S., Gillett, Godfrey T., Tsochatzis, Emmanuel A., Rowe, James B., Gerhard, Alex, Butler, Chris R., Masellis, Mario, Bremner, Fion, Martin, Alison, Jung, Lynne, Cook, Paul, Zetterberg, Henrik, Bandmann, Oliver, Rohrer, Jonathan D., Warner, Thomas T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436757/
https://www.ncbi.nlm.nih.gov/pubmed/33078859
http://dx.doi.org/10.1002/mds.28333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436757/
https://www.ncbi.nlm.nih.gov/pubmed/33078859
http://dx.doi.org/10.1002/mds.28333

Ejemplares similares